Property Art. 04 Life Sciences Leases
Office complexity, industrial complexity, regulatory layers on top.
Specialized buildouts. Hazardous materials at scale. Decommissioning obligations. Infrastructure requirements that double as both lease specifications and ongoing maintenance responsibilities.
LeasePilot encodes the distinctions between pharma R&D, biotech manufacturing, and clinical lab, and applies them to every draft.
Sound familiar?
- 01
Shell conditions, specialized MEP, phased TI tied to milestones
- 02
Chemicals, biologics, radiological materials with tenant-specific tiers
- 03
Decommissioning: who pays, what standard, what if contamination is found
- 04
Emergency power, lab gas, ventilation, backup cooling as base requirements
Lab leases live where two complex worlds collide.
The TI looks like office, but the disbursements are tied to a clean-room sign-off. The hazmat looks like industrial, but the tenant ships biologics. The decommissioning isn't in your office form or your industrial form, because every lab vacancy ends with a contamination question that needs a defined answer.
Underspecified provisions land the cleanup bill on the landlord. Lab-specific provisions need to be lab-specific in your platform.
- 01
Lab buildout complexity
Shell-condition definitions, specialized MEP requirements, vivarium provisions, clean-room specs. TI structures are larger and more complex than standard office, with phased disbursements tied to construction milestones.
- 02
Hazardous materials at scale
Chemicals, biologics, radiological materials. Storage, handling, reporting, and disposal vary by tenant type, pharma R&D vs. biotech manufacturing vs. medical device.
- 03
Decommissioning obligations
When a lab tenant vacates, the space must be decommissioned to a defined standard. Who pays, what standard, what happens if contamination is discovered.
- 04
Specialized infrastructure
Emergency power, lab gas, chemical-waste neutralization, ventilation rates by room type, backup cooling. These aren't options, they're base building.
You describe the deal. The platform writes the lab lease.
Your life-sciences forms, encoded with conditional logic that handles the variations across tenant types, pharma R&D vs. biotech manufacturing vs. clinical lab, and building configurations.
Lab buildout provisions, hazmat tiers, decommissioning standards, and infrastructure specifications all adjust based on the deal parameters you have defined.
You describe the deal
- Property
- Cambridge Bio Center
- Tenant
- Helix Therapeutics
- Suite
- Lab 500
- RSF
- 22,000
- Term
- 10 years
- Use
- Pharma R&D
LeasePilot resolves
Life Sciences Lease · Helix Therapeutics, Lab 500
- 01Phased TI for lab-buildout milestones
- 02Hazmat tier (biologics + chemicals)
- 03Decommissioning standard & cost allocation
- 04Ventilation rates by room classification
- 05EH&S compliance during construction
Four areas where lab leases create landlord exposure
- § 04.A
Lab Buildout & TI
Shell conditions, milestone-based disbursements, lab-specific oversight, EH&S during construction.
- Shell-condition definitions for lab space
- Phased TI disbursement tied to milestones
- Landlord oversight of lab-specific systems
- EH&S compliance during construction
- § 04.B
Hazardous Materials
Permitted materials by tenant use, manifesting, radiological materials. Scaled to the tenant's actual program.
- Permitted materials by tenant use category
- Storage and handling requirements
- Reporting and manifesting obligations
- Disposal and radiological-materials provisions
- § 04.C
Decommissioning
Baseline at commencement, defined standard at exit, cost allocation, post-vacancy testing.
- Baseline environmental assessment at commencement
- Decommissioning standard and scope
- Cost allocation and timeline requirements
- Post-vacancy environmental testing
- § 04.D
Infrastructure & Regulatory
Emergency power, lab gas, chemical-waste neutralization, biosafety and DEA licensing.
- Emergency power and generator capacity
- Lab gas systems and ventilation rates
- Chemical-waste neutralization requirements
- Institutional biosafety and DEA licensing
These are illustrative. Your platform is custom-built around your specific lease forms and deal logic.
A template won't catch the decommissioning baseline. The platform will.
Word + Excel
Manual assembly
Patch your office TI section onto your industrial hazmat section. Hope the decommissioning is somewhere. Hope the ventilation rates match the building's actual capacity.
AI tools
Approximate output
An LLM can write decommissioning language that sounds defensible. It can't reliably scale hazmat to a clinical-trial program, or know that this building's emergency power tops out at 800 kVA.
LeasePilot
Encoded judgment
Your life-sciences forms, your hazmat tiers, your decommissioning standards, encoded and executable. Same deal parameters, same document, every time.
- § 01 · Coverage
0%
Decommissioning baselines, standards, and cost allocation, always specified.
- § 02 · Tenant types
0
Pharma R&D, biotech manufacturing, clinical lab, each with its own hazmat tier and provisions.
- § 03 · Property profile
0
Ventilation rates, generator capacity, lab gas, entered once, applied to every document.
CASTO
“I have been using LeasePilot for almost 10 years. I cannot imagine going back to drafting leases where all fields, exhibits, and signature blocks must be inserted manually. This tool has been a game changer.”
Julia F.
VP & Assistant General Counsel, CASTO
- 01 · SolutionIndustrial LeasesIndustrial-specific provisions including environmental liability and hazmat compliance.
- 02 · SolutionOffice LeasesTI and option provisions for the office components labs often share.
- 03 · SolutionAmendments & ModificationsKeep your life-sciences document set consistent across amendments and expansions.
See your lab leases drafted in your platform.
Send us a template ahead of time. We will demo with your actual forms, your hazmat tiers, and a deal that looks like one your team would draft tomorrow.